Avantax Advisory Services, Inc. Vericel Corp Transaction History
Avantax Advisory Services, Inc.
- $17.6 Billion
- Q2 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 18,395 shares of VCEL stock, worth $585,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,395
Previous 15,915
15.58%
Holding current value
$585,880
Previous $710,000
10.14%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VCEL
# of Institutions
295Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$257 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$113 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$89.6 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$78.5 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$77.6 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.5B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...